• Institutions
    • NEURO
    • FAPSE
    • HUG
  • Research
    • Research groups
    • Publications
  • Education
    • Master
    • PhD
  • Outreach
  • Events
    • Agenda
    • Photo Gallery
  • About us

Geneva University Neurocenter

  • fr
  • en

Or you can search on UNIGE website (advanced-search)  
  • Institutions
    • NEURO
    • FAPSE
    • HUG
  • Research
    • Research groups
    • Publications
  • Education
    • Master
    • PhD
  • Outreach
  • Events
    • Agenda
    • Photo Gallery
  • About us

Agenda

Loading Events

« All Events

  • This event has passed.

Unlocking the Power of 3D Cell Culture.

4 June @ 14 h 15 min - 15 h 45 min

  • « Séminaire de Sébastien Ballesta: “Toward neuroanatomical and cognitive foundations of social tolerance across macaque species”
  • NC Talk: “Connectivité et plasticité des réseaux neurocognitifs : contributions de la cartographie lésionnelle et de l’électrostimulation directe chez des patients atteints de tumeur cérébrale” »

Involved in advanced cell research in academia and industry, OMNI Life Science company (Dr Demiral) will illustrate the CERO 3D Incubator and Bioreactor and the optimized cultivation of stem cells, spheroids, organoids and tissue biopsies in short- and long-term cultures.

+ Google Calendar+ iCal Export

Details

Date:
4 June
Time:
14 h 15 min - 15 h 45 min
Event Category:
Seminars neurobiology
Website:
http://agenda.unige.ch/events/view/45957

Venue

A04.2906

Related Events

  • Basic Neuroscience Intra-department Seminars: “TBA”

    Basic Neuroscience Intra-department Seminars: “TBA”

    25 June @ 16 h 00 min - 17 h 00 min
  • Séminaire de Laurent Sheybani: “TBA”

    Séminaire de Laurent Sheybani: “TBA”

    21 September @ 11 h 00 min - 12 h 00 min
  • « Séminaire de Sébastien Ballesta: “Toward neuroanatomical and cognitive foundations of social tolerance across macaque species”
  • NC Talk: “Connectivité et plasticité des réseaux neurocognitifs : contributions de la cartographie lésionnelle et de l’électrostimulation directe chez des patients atteints de tumeur cérébrale” »
Geneva University Neurocenter